All News about Relief Therapeutics Hldg Ag
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/21211.jpg?v=1)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/21211.jpg?v=1)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/21211.jpg?v=1)
Relief Therapeutics Launches Level 1 ADR Program in the United States
November 18, 2021
Via AccessWire
Exposures
COVID-19
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/21211.jpg?v=1)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/21211.jpg?v=1)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/21211.jpg?v=1)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_2391.png)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/21211.jpg?v=1)
Via AccessWire
Exposures
COVID-19
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/21211.jpg?v=1)
Via AccessWire
Exposures
COVID-19
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/21211.jpg?v=1)
Via AccessWire
Exposures
COVID-19
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_2273.png)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/21211.jpg?v=1)
Via AccessWire
Exposures
COVID-19
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/21211.jpg?v=1)
Relief Therapeutics Reports Two Publications of Positive Data on Nexodyn(R) AOS for Hard-to-Heal Ulcers
October 20, 2021
Via AccessWire
Exposures
COVID-19
![](https://g.foolcdn.com/editorial/images/646850/judge-with-gavel.jpg)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/21211.jpg?v=1)
Via AccessWire
Exposures
COVID-19
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/21211.png?v=0)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/21211.png?v=0)
Via AccessWire
Topics
Lawsuit
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_2121.png)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/21211.png)
Via AccessWire
Exposures
COVID-19
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/medic-563423_1920_398_59.jpg)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/21211.png)
Via AccessWire
Exposures
COVID-19
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/21211.png)
Via AccessWire
Exposures
COVID-19
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/21211.png)
Relief Reports Half-Year 2021 Results and Provides Corporate Update
September 24, 2021
Via AccessWire
Topics
Intellectual Property
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/21211.png)
Via AccessWire
Exposures
COVID-19
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/21211.png)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/21211.png)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/21211.png)
Relief Therapeutics to Participate in the H.C. Wainwright 23rd Annual Global Investment Conference
September 08, 2021
Via AccessWire
Exposures
COVID-19
![](https://storage.googleapis.com/accesswire/logos/subaccounts/21211.png)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/21211.png)
Via AccessWire
Exposures
COVID-19
![](https://storage.googleapis.com/accesswire/logos/subaccounts/21211.png)
Via AccessWire
Exposures
COVID-19
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.